Concepedia

Author

Lijuan Huo

Shanxi Medical UniversityORCID

Also Known As

HUO Lijuan, Li-Juan Huo, Li-juan Huo, Lijuan Huo, Li‐juan Huo

28

Publications

302

Citations

9

H-Index

9

Concepts

All Affiliations

Shanxi Medical UniversityFirst Hospital of Shanxi Medical UniversityNanchang UniversitySun Yat-sen UniversityCentral South University
LH

About

Lijuan Huo is an author at Shanxi Medical University specializing in portfolio optimization, uncertainty quantification, and engineering.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Engineering

1

1

23

2

Management

1

1

23

3

Finance

1

1

23

4

Asset Pricing

1

1

23

5

Statistics

1

1

23

Lijuan Huo

×

9

Publications

290

Citations

9

H-Index

YearCitations

Association between social participation and cognitive function among middle- and old-aged Chinese: A fixed-effects analysis

Yongjie Zhou, Zhuo Chen, Ian Shaw,

Journal of Global Health

2020

69

Long-term follow-up of <i>Helicobacter pylori</i> reinfection and its risk factors after initial eradication: a large-scale multicentre, prospective open cohort, observational study

Yong Xie, Conghua Song, Hong Cheng,

Emerging Microbes & Infections

2020

47

On‐treatment changes of liver stiffness at week 26 could predict 2‐year clinical outcomes in <scp>HBV</scp>‐related compensated cirrhosis

Shanshan Wu, Yuanyuan Kong, Hongxin Piao,

Liver International

2017

39

Antioxidant axis Nrf2-keap1-ARE in inhibition of alcoholic liver fibrosis by IL-22

Ya-Hui Ni, Lijuan Huo, Tingting Li

World Journal of Gastroenterology

2017

36

Diagnosis and treatment of <i>Helicobacter pylori</i> infection by physicians in China: A nationwide cross‐sectional study

Zhiqiang Song, Ye Chen, Hong Lü,

Helicobacter

2022

32

Robust estimation of covariance and its application to portfolio optimization

Lijuan Huo, Tae-Hwan Kim, Yunmi Kim

Finance research letters

2012

23

Furazolidone‐containing triple and quadruple eradication therapy for initial treatment for <i>Helicobacter pylori</i> infection: A multicenter randomized controlled trial in China

Yong Xie, Zhenyu Zhang, Junbo Hong,

Helicobacter

2018

21

Mucosal Healing Effectiveness and Safety of Anaprazole, a Novel PPI, vs. Rabeprazole in Patients With Duodenal Ulcers: A Randomized Double-Blinded Multicenter Phase II Clinical Trial

Xu Shu, Zhenhua Zhu, Yu Fu,

Frontiers in Medicine

2021

12

Efficacy of keverprazan for duodenal ulcer: A phase II randomized, double‐blind, parallel‐controlled trial

Niandi Tan, Xiaowei Liu, Chengxia Liu,

Journal of Gastroenterology and Hepatology

2022

11

Page 1